Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, Olivier Bouche, Eric Assenat, Guillaume Piessen, Pascal Hammel, Nicolas Regenet, Julien Taieb, Olivier Turrini, Francois Paye, Anthony Turpin, Francois-Regis Souche, Christophe Laurent, Reza Kianmanesh, Pierre Michel, Dewi Vernerey, Jean-Yves Mabrut, Celia Turco, Stephanie Truant, Antonio Sa Cunha, Eric Terrebonne, Angele Vienot, Nicolas Tabchouri, Fabienne Portales, Alain Sauvanet, Mickael Lesurtel, Olivia Hentic, Jean-Christophe Vaillant, Christope Tournigand, Rim Cherif, Emmanuel Buc, Caroline Petorin, Jean Christophe Souquet, Jean-Marc Regimbeau, Bruno Chauffert, Laurent Sulpice, Eveline Boucher, Thierry André, Stephane Benoist, Anne Thiro-Bidault, Ahmet Ayav, Laurence Choné, Jean Frederic Blanc, Maximiliano Gelli, David Malka, Yann Touchefeu, Vincent Moutardier, Laëtitia Dahan, Emmanuel Mitry, Jean Lubrano, Karine Bouhier Leporrier, David Fuks, Christophe Louvet, David Tougeron, Jean-Pierre Richer, Emilia Ragot, Thierry Lecomte, Romain Coriat, Sebastien Gaujoux. "Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco-24-01378